
By Marketwired . | Article Rating: |
|
March 14, 2012 04:46 PM EDT | Reads: |
514 |

NEWTON, MA -- (Marketwire) -- 03/14/12 -- Recombinant Data, a healthcare data warehousing and clinical intelligence solutions provider, today announced that the company will lead a panel on translational bioinformatics and clinical research informatics at the AMIA 2012 Joint Summits on Translational Science held from March 19 - 23 in San Francisco. Featured presenters include clinicians, researchers, and scientists from City of Hope, Kimmel Cancer Center at Jefferson, and the University of California, Irvine.
The panel will be held on Thursday, March 22 from 12:15 p.m. - 1:15 p.m. PT. Michael Kamerick, managing director of Health Systems Solutions at Recombinant Data, will moderate. Panelists include:
- Jack London, PhD, Informatics Shared Resource Center Director, Kimmel Cancer Center at Jefferson, who will describe how he and his team created biospecimen and tumor registries and are expanding data sets to include clinical trial, ambulatory care, and biomarker data using the Recombinant Data Trust data warehouse and i2b2.
- Leanne Streja, DrPH, Senior Programmer Analyst, Srisairam Achuthan, PhD, MS, Senior Scientific Programmer, City of Hope, an NCI-designated Comprehensive Cancer Center, who will present how they developed and leverage their i2b2-based iCoDE (Interactive Cohort Discovery Engine) for clinical and biospecimen data integration.
- Lisa Dahm, PhD, Director, Clinical Informatics, University of California, Irvine, who will discuss the UC-ReX project in which i2b2 and the Shared Health Research Information Network (SHRINE) are being used to create a federated data warehouse serving the five University of California medical center campuses: UCLA; UC, San Diego; UC, San Francisco; UC, Davis; and UC, Irvine.
Recombinant Data offers Professional Open Source Support (POSS) for institutions adopting i2b2 and other open source software projects including SHRINE, caTissue, Profiles Research Networking Software, and the Research Permission Management System, to gain the benefits of open source with the dependability of commercial software for clinical and translational research.
About Recombinant Data Corp.
Recombinant provides leading-edge data warehousing and clinical intelligence solutions to healthcare providers, academic medical centers and life science researchers to deliver higher quality outcomes, accelerate personalized medicine, and lower costs. Our team of industry veterans is focused on improving the flow of reliable data to power clinical and research applications in a secure, compliant environment. For more information about Recombinant's products and services, visit www.recomdata.com.
Twitter: @Recomdata, #recomdata, @AMIAinformatix, #TBICRI12
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact:
Chas Kielt
Corporate Marketing and Communications
617-243-3700 X366
[email protected]
Bill Stetson
Marketing Manager
617-243-3700 X229
[email protected]
Published March 14, 2012 Reads 514
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
![]() Feb. 16, 2019 08:45 AM EST Reads: 14,062 |
By Yeshim Deniz ![]() Feb. 16, 2019 05:45 AM EST |
By Yeshim Deniz Feb. 16, 2019 03:15 AM EST |
By Zakia Bouachraoui Feb. 16, 2019 01:00 AM EST |
By Pat Romanski Feb. 16, 2019 12:15 AM EST |
By Zakia Bouachraoui ![]() Feb. 15, 2019 03:15 PM EST |
By Zakia Bouachraoui Feb. 15, 2019 03:00 PM EST |
By Roger Strukhoff Feb. 14, 2019 05:00 PM EST |
By Elizabeth White Feb. 13, 2019 08:15 PM EST |
By Liz McMillan Feb. 13, 2019 06:45 PM EST |